Survey of the 1999 surface plasmon resonance biosensor literature
RL Rich, DG Myszka - Journal of molecular recognition, 2000 - Wiley Online Library
The application of surface plasmon resonance biosensors in life sciences and
pharmaceutical research continues to increase. This review provides a comprehensive list of …
pharmaceutical research continues to increase. This review provides a comprehensive list of …
Functional mapping and single chain construction of the anti-cytokeratin 8 monoclonal antibody TS1
The anti-cytokeratin (CK) 8 monoclonal antibody (mab) TS1 has been shown to efficiently
bind to CK8 expressed in carcinomas in vivo. The anti-idiotypic antibody of TS1, αTS1, can …
bind to CK8 expressed in carcinomas in vivo. The anti-idiotypic antibody of TS1, αTS1, can …
Cytokeratin fragments in the serum: their utility for the management of oral cancer
SS Sawant, SM Zingde, MM Vaidya - Oral oncology, 2008 - Elsevier
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy
and is a major cause of cancer morbidity and mortality worldwide. Oral cancer is the most …
and is a major cause of cancer morbidity and mortality worldwide. Oral cancer is the most …
Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus
T Makino, M Yamasaki, A Takeno, M Shirakawa… - British journal of …, 2009 - nature.com
Background: Cytokeratins (CKs) are structural marker proteins specific for epithelial cells.
However, recent studies indicate their involvement in cancer progression. Methods: We …
However, recent studies indicate their involvement in cancer progression. Methods: We …
Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization
EJ Bonten, Y Campos, V Zaitsev, A Nourse… - Journal of Biological …, 2009 - ASBMB
Lysosomal neuraminidase-1 (NEU1) forms a multienzyme complex with β-galactosidase
and protective protein/cathepsin A (PPCA). Because of its association with PPCA, which acts …
and protective protein/cathepsin A (PPCA). Because of its association with PPCA, which acts …
Idiotypic–anti‐idiotypic complexes and their in vivo metabolism
A Johansson, A Erlandsson, D Eriksson… - … Journal of the …, 2002 - Wiley Online Library
BACKGROUND Different strategies can be used to improve the tumor: non‐tumor ratio of
radiolabeled antibodies in immunotargeting. One approach is to use secondary antibodies …
radiolabeled antibodies in immunotargeting. One approach is to use secondary antibodies …
The Versatility of Cytokeratins asTumor Markers
T Stigbrand - Tumor biology, 2000 - karger.com
Cytokeratins are particularly versatile tools in tumor biology both experimentally and
clinically. Previously regarded as a rigid intracellular skeleton, the cytokeratins are now …
clinically. Previously regarded as a rigid intracellular skeleton, the cytokeratins are now …
Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine
S Wittke, S Baxmann, D Fahlenkamp… - OncoTargets and …, 2016 - Taylor & Francis
Purpose An autologous tumor vaccine already used successfully in the immune therapy of
renal cell carcinoma was investigated in detail. The evaluation of potential tumor markers …
renal cell carcinoma was investigated in detail. The evaluation of potential tumor markers …
Construction of divalent anti-keratin 8 single-chain antibodies (sc (Fv) 2), expression in Pichia pastoris and their reactivity with multicellular tumor spheroids
Single-chain variable fragments (scFvs) are small monovalent recombinant antibody
fragments that retain the specificity of their parent immunoglobulins. ScFvs are excellent …
fragments that retain the specificity of their parent immunoglobulins. ScFvs are excellent …
Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19: Second report of the TD5 workshop
M Nap, T van Wel, C Andres, L Bellanger… - Tumor biology, 2000 - karger.com
In the first report of the TD5 workshop (TD5-1), the epitope specificities of 30 different
monoclonal antibodies against cytokeratins 8, 18 and 19 were determined. This second …
monoclonal antibodies against cytokeratins 8, 18 and 19 were determined. This second …